Cargando…
Mir-153-3p Modulates the Breast Cancer Cells’ Chemosensitivity to Doxorubicin by Targeting KIF20A
SIMPLE SUMMARY: Breast cancer is a disease that begins in the cells of the breast. Although it is most common in women, it can also occur in men, though this is rare. Early detection and treatment are crucial to improving outcomes and survival rates. Risk factors include age, family history, certain...
Autores principales: | Rahman, Khalil Ur, Yang, Shuo, Azam, Nasir, Yuan, Zhen, Yu, Jiawen, Zhao, Chunhui, Feng, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046630/ https://www.ncbi.nlm.nih.gov/pubmed/36980610 http://dx.doi.org/10.3390/cancers15061724 |
Ejemplares similares
-
Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC
por: Wu, Chuanxing, et al.
Publicado: (2021) -
The Role of Kif4A in Doxorubicin-Induced Apoptosis in Breast Cancer Cells
por: Wang, Hui, et al.
Publicado: (2014) -
A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells
por: Yousefnia, Saghar
Publicado: (2022) -
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
por: Liffers, Sven-T, et al.
Publicado: (2013) -
Targeting Cellular Metabolism Chemosensitizes the Doxorubicin-Resistant Human Breast Adenocarcinoma Cells
por: Ma, Shulan, et al.
Publicado: (2015)